跳至主要内容
临床试验/CTRI/2024/12/078831
CTRI/2024/12/078831尚未招募不适用

Comparative Clinical Study of Kamala Arka and Taruni Arka in Hyperpigmentation

J S Ayurved Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年1月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Changes in signs of hyperpigmentation

研究概览

简要总结

This study is Randomized clinical trial to evaluate the effect of Kamala(Nelumbo nucifera Gaertn.) Arka and Taruni (Rosa centifolia Linn.) Arka on hyperpigmentation. 40 patients fulfilling the inclusion criteria will be selected from OPD and randomly divided into two groups of 20 patients in each group. Medicine in the form of Arka prepared from Kamala and Taruni will be given to the patients of hyperpigmentation to apply externally on the affected part of the face twice a day. Duration of application will be of 3 months. Patients will be assessed before and after the treatment.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients having signs of hyperpigmentation (dark patches) on face fulfilling the diagnosis will be included.

排除标准

  • 1.Patients having any other diseases like AIDS, STD, itching, wound, active acne, burning, eczema, dermatitis and other disorders which lead to fatal condition for the patients.
  • 2.Birth marks and moles will be excluded.
  • 3.Pregnant and lactating women.
  • 4.Patients who are on corticosteroid drugs or immune-suppressants and past history of steroidal use in the last 6 months.
  • 5.Other concomitant skin disease occurring with allergic reaction of any other disease.

结局指标

主要结局

Changes in signs of hyperpigmentation

时间窗: 12 weeks

次要结局

  • Difference in clinical efficacy of Kamala Arka and Taruni Arka(12 weeks)

研究者

发起方
J S Ayurved Mahavidyalaya
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Khushbu Rajeshbhai Morker

J. S. Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验